doi: 10.1038/s43587-025-00864-8 169 SandekA.BjarnasonI.VolkH
In other cases, the drugs help the body handle blood sugar and fat, making people more metabolically flexible and biochemically more youthful, said Dr
Serious adverse events with tirzepatide are rare but include pancreatitis, gallbladder problems, and potential thyroid concerns (based on animal studies)
We honestly arent trying to toot our own horn here, but its important to do a little research and find a facility with the skill and the tools to treat you right
In April 2026, the FDA granted approval to two oral GLP-1 treatments, Eli Lillys Foundayo, made with orforglipron, and Novo Nordisks semaglutide pill, also called Wegovy